8:32 AM ET
8-K
M&A Deal
Xflh Capital M&A Deal with Renogen Biolab Inc.
XFLH Capital Corporation, a SPAC, has signed a non-binding letter of intent for a business combination with Renogen Biolab Inc., a Canadian health service provider specializing in molecular capabilities such as DNA services and vector engineering. The parties are now working to negotiate definitive agreements and conduct mutual due diligence to finalize the merger.
- Counterparty
- Renogen Biolab Inc.